Pharmaceutical - France

Filter

Current filters:

France

Popular Filters

1 to 25 of 59 results

Ipsen appoints François Garnier as executive vice president, general counsel

Ipsen appoints François Garnier as executive vice president, general counsel

17-12-2014

French drugmaker Ipsen has appointed François Garnier as executive vice president, general counsel of…

BoardroomFranceIpsenIpsen GroupPharmaceutical

Ipsen Phase III trial shows benefits of combining tamoxifen and triptorelin in breast cancer survival

Ipsen Phase III trial shows benefits of combining tamoxifen and triptorelin in breast cancer survival

12-12-2014

French drugmaker Ipsen has announced results of a trial evaluating the use of ovarian suppression as…

DecapeptylFranceIpsenOncologyPharmaceuticalResearchtamoxifentriptorelin pamoate

Sanofi accused of $34 million kickbacks by former paralegal employee

Sanofi accused of $34 million kickbacks by former paralegal employee

05-12-2014

Allegations have been made that French drug major Sanofi and members of its executive took part in a…

FranceLantusLegalNephrology and HepatologyPharmaceuticalSanofi

Evotec and Sanofi negotiate 250 million euro strategic collaboration

Evotec and Sanofi negotiate 250 million euro strategic collaboration

03-12-2014

German biotech company Evotec has entered into exclusive negotiations with French drug major Sanofi on…

EvotecFranceGermanyPharmaceuticalResearchSanofi

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

02-12-2014

French drug major Sanofi and North Carolina-based pharma company Pozen have agreed to end their collaboration…

FranceGastro-intestinalsLicensingPA8140/PA32540PharmaceuticalPozenSanofiUSA

Recipharm acquires Flamel Technologies facility in France

27-11-2014

Swedish pharmaceutical contract development and manufacturing organization Recipharm AB and French drug…

Flamel TechnologiesFranceMergers & AcquisitionsPharmaceuticalProductionRecipharm

France negotiates lowest price in Europe for Gilead’s Sovaldi

France negotiates lowest price in Europe for Gilead’s Sovaldi

21-11-2014

The discount negotiated by the French government on hepatitis C drug Sovaldi (sofosbuvir), produced by…

FranceGilead SciencesNephrology and HepatologyPharmaceuticalPoliticsPricingRegulationSovaldi

Ipsen partners with academia to launch Archi-Pex research site

Ipsen partners with academia to launch Archi-Pex research site

21-11-2014

French drugmaker Ipsen and the French National Center for Scientific Research are to launch the Archi-Pex…

Cross-linked polyethyleneFranceIpsenPharmaceuticalProductionResearchSoftware

Positive results for Sanofi/Regeneron’s dupilumab in asthma

Positive results for Sanofi/Regeneron’s dupilumab in asthma

11-11-2014

French pharma major Sanofi and US partner Regeneron Pharmaceuticals have released positive results from…

dupilumabFrancePharmaceuticalRegeneron PharmaceuticalsResearchRespiratory and PulmonarySanofi

French regulator requests information from Roche on off-label use of Avastin for wet-AMD

French regulator requests information from Roche on off-label use of Avastin for wet-AMD

07-11-2014

The French pharma regulator, l’Agence nationale de sécurité du médicament et des produits de santé…

AvastinFranceOphthalmicsPharmaceuticalRegulationRoche

Sanofi reports positive data in Phase III dengue vaccine trial, with 95.5% efficacy against severe dengue

Sanofi reports positive data in Phase III dengue vaccine trial, with 95.5% efficacy against severe dengue

04-11-2014

French drug major Sanofi has reported positive data with its experimental tetravalent dengue vaccine…

Anti-viralsFrancePharmaceuticalResearchSanofi Pasteur

NicOx's acquisitions pay off as sales rocket to 4 million euros in third quarter

NicOx's acquisitions pay off as sales rocket to 4 million euros in third quarter

30-10-2014

French pharma company NicOx has achieved sales of 4 million euros ($5 million) in the third quarter of…

FinancialFranceNicOxOphthalmicsPharmaceutical

Specialty care and Somatuline drive Ipsen's positive third quarter financials

Specialty care and Somatuline drive Ipsen's positive third quarter financials

29-10-2014

French drugmaker Ipsen has reported sales of 329 million euros ($419.1 million) for the third quarter…

DysportFinancialFranceIpsenPharmaceuticalSomatuline

Sanofi ousts CEO Viehbacher, despite recent denials

Sanofi ousts CEO Viehbacher, despite recent denials

29-10-2014

Just a day after French pharma major Sanofi denied that the future of its chief executive was under discussion,…

BoardroomFranceManagementPharmaceuticalSanofi

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

28-10-2014

French drug major Sanofi’s third-quarter earnings are in focus, but the company’s shares have plummeted…

FinancialFranceGenzymePharmaceuticalSanofi

UPDATED: Sanofi chief executive Viehbacher allegedly issues letter to company board defending his position

UPDATED: Sanofi chief executive Viehbacher allegedly issues letter to company board defending his position

28-10-2014

Chris Viehbacher, chief executive of French drug major Sanofi, has urged the company’s board to clarify…

BoardroomFranceLantusPharmaceuticalSanofi

Sanofi Pasteur and Immune Design announce herpes vaccine collaboration

Sanofi Pasteur and Immune Design announce herpes vaccine collaboration

16-10-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, and Immune Design, a clinical-stage…

FranceImmune DesignPharmaceuticalResearchSanofi PasteurVaccines

Nanobiotix to receive $1 million milestone after global trial expanded

Nanobiotix to receive $1 million milestone after global trial expanded

08-10-2014

French nanomedicine company Nanobiotix says that its partner PharmaEngine will join its pivotal trial…

Asia-PacificFranceNanobiotixNBTXR3OncologyPharmaceuticalPharmaEngineResearch

Sanofi receives allegations of improper payments dating back seven years

Sanofi receives allegations of improper payments dating back seven years

07-10-2014

French pharma major Sanofi has notified the US Department of Justice and the US Securities and Exchange…

East AfricaFranceLegalMiddle EastPharmaceuticalSanofiUS Department of JusticeUS Securities and Exchange Commission

French Transparency Commission recognizes efficacy of Eisai’s Zonegran monotherapy

French Transparency Commission recognizes efficacy of Eisai’s Zonegran monotherapy

06-10-2014

Transparency advice for Japanese pharma major Eisai’s Zonegran (zonisamide) monotherapy in the treatment…

EisaiFranceNeurologicalPharmaceuticalRegulationZonegran

Servier’s new research partnership with Walter and Eliza Hall Institute

Servier’s new research partnership with Walter and Eliza Hall Institute

04-10-2014

French independent pharma company Servier has established a collaborative partnership with Australia’s…

AustraliaFranceOncologyPharmaceuticalResearchServier

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

01-10-2014

French drug major Sanofi and US biotech company Regeneron's dupilumab has met all primary and secondary…

dupilumabFrancePharmaceuticalRegeneronResearchRespiratory and PulmonarySanofiUSA

NicOx and Valeant's glaucoma candidate Vesneo meets Ph III endpoint

NicOx and Valeant's glaucoma candidate Vesneo meets Ph III endpoint

25-09-2014

Canada’s Valeant Pharmaceuticals International and France’s NicOx have reported positive top-line…

Bausch & LombCanadaFinancialFranceNicOxOphthalmicsPharmaceuticalResearchValeant Pharmaceuticals InternationalVesneo

1 to 25 of 59 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top